CIENCIA ABIERTA Y PROPIEDAD INTELECTUAL Open science and intellectual property (IP) regulation share the same fundamental objective of promoting innovation for social, scientific and economic development. However, there may be some tension due to the fact that IP rights can be used as a basis for controlling and managing the way in which protected subject ... Read more
To celebrate the World Environment Day (5 June) IBEC’s Sustainability Committee is organizing a second-hand exchange market! You can bring those pieces of clothing and lab materials that are clean and in good shape, but you don’t use anymore, and take one for free! SAVE THE DATE: 📅 21st of June 📍 in front of ... Read more
Multimode User Day Agenda: 1. Absorbance, Fluorescence and Luminescence reading modes 1. Incubation options: gas, temperature, shaking, injectors,… 2. Brightfield Imaging 3. Fluorescence Imaging 4. Hands-on session: SparkCyto Where? Parc Científic de Barcelona c/Baldiri Reixach, 10. Torre I, Floor 11, Sala Baobab (IBEC) When? 25th June 2024 (Tuesday), 14-17h Organizer: Institute for Bioengineering of ... Read more
As part of IBEC's science education initiatives, this year we have been running the IMAB project, which aims to bring the latest advances in bioengineering in organ and tissue regeneration to the over-65s. The aim of the project, beyond being a dissemination activity, has been to gather their impressions and transmit them to the scientific ... Read more
Laboratories consume three to five times more energy and resources than standard office spaces, with significant environmental impacts from constant equipment operation and disposable plastic use. Against this background, the project ‘Sustainable Laboratories’ (NACH-LABS), a joint effort of the Hamburg University of Applied Sciences, the Technical University of Darmstadt, and IUTA e.V., the European School of Sustainability Science and ... Read more
Developability assessment of biologics and formulation of novel molecules Shahid Uddin, PhD, MBA, Senior Director of Drug Product, Formulation & Stability within the CMC department at Immunocore, UK It’s vital to ensure appropriate assessment of molecules at the early research phase is carried out to risk mitigate movement into the development phase. This ensures the best risk ... Read more
Nanomedicine to Tackle Unmet Medical Needs in CNS Disorders Sabina Quader, Innovation Center of NanoMedicine (iCONM), Kawasaki Institute of Industrial Promotion, Kawasaki, Kanagawa 210-0821 Japan The brain is undoubtedly the body's most essential and intricate organ, and brain disorders are closely tied to this intricacy. Categorized as "CNS diseases," a wide range of brain-related conditions - ... Read more
Semi-synthetic nucleosomes to stabilize and image enzyme-chromatin interactions Carlos Moreno Yruela, Researcher in Chemical Biology, EPFL, Switzerland Chromatin structure regulates gene expression and is tightly controlled by histone post-translational modifications. SIRT7 is a histone lysine deacylase found to maintain oncogenic gene expression profiles supporting tumor growth and metastasis. Interestingly, the activity of SIRT7 is fully ... Read more
Harnessing the power of stem cell therapy in an off-the-shelf nano-delivery platform for treating brain disorders Prof Marcelle Machluf, Faculty of Biotechnology and Food Engineering, Technion, Haifa, Israel Mesenchymal stem cells (MSCs) have gained the most attention in cell therapy, owing to their ability to traverse physiological barriers, and target different sites of inflammation including ... Read more
Advances in understanding and manipulating influenza A virus liquid inclusions Maria João Amorim, PhD, Group Leader, Cell Biology of Viral Infection Lab, Católica Biomedical Research Centre, Universidade Católica Portuguesa, and Instituto Gulbenkian de Ciência, Portugal Many viruses form biomolecular condensates de novo as part of their replication programmes. Influenza A virus is an important human pathogen ... Read more